Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study

BACKGROUND: The current standard for induction phase treatment of lupus nephritis is steroid combined with mycophenolate mofetil or pulse intravenous cyclophosphamide (IVC). The lowest dose of IVC recommended for induction therapy is that used in the Euro-Lupus Trial. It is not known whether same cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sigdel, Mahesh R., Kafle, Mukunda P., Shah, Dibya Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055665/
https://www.ncbi.nlm.nih.gov/pubmed/27717323
http://dx.doi.org/10.1186/s12882-016-0361-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055665/
https://www.ncbi.nlm.nih.gov/pubmed/27717323
http://dx.doi.org/10.1186/s12882-016-0361-0

Ejemplares similares